Evidence map›Paper›PMID 34235578›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2022

COVID-19 caused hearing loss.

Milisavljevic Dusan, Stankovic Milan, Dordevic Nikola

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05052320 (Audiological Assessment of Recovered Covid 19 Subjects.), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05052320 unknown statusnot on this map

Audiological Assessment of Recovered Covid 19 Subjects.

Typeobservational_patient_registrySponsorAssiut UniversityRan2021 to 2023Enrolled70ConditionsCovid 19ArmsAudiological assessment
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Neuroscientific therapies for subjective tinnitus.Journal of Zhejiang University. Science. B · 2026
    Review
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. COVID-19 and its effect on hearing.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Article
  13. Slight High-Frequency Hearing Loss, Effect of COVID-19 or Hydroxychloroquine Usage?Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2022
    Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Milisavljevic DusanDepartment of Otolaryngology, University Clinic Centre Nis, Bul. Zorana Đinđića 48, Nis, Serbia. dusanorldusan@gmail.com.ORCID http://orcid.org/0000-0003-0598-2392
Stankovic MilanDepartment of Otolaryngology, University Clinic Centre Nis, Bul. Zorana Đinđića 48, Nis, Serbia.
Dordevic NikolaDepartment of Otolaryngology, University Clinic Centre Nis, Bul. Zorana Đinđića 48, Nis, Serbia.
University of Nis · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe objective of this cross-sectional study was to determine if there is a potential link between COVID-19 infection and hearing loss.

methodsThe prospective study was conducted in the COVID Hospital Clinical Centre Niš, Serbia. We performed tonal audiometry and used a custom questionnaire and medical histories to determine the incidence of hearing loss in COVID-19 positive patients.

resultsThere were 74 patients with COVID-19 that met the inclusion criteria of this study and they composed our experimental group. Fifty-four (73%) were men and 20 (27%) women. There were 30 (40.5%) patients with hearing loss. Seventeen patients had unilateral and 13 had bilateral hearing loss. Significant differences between hearing loss groups and control group were found across all age groups, but not at all frequencies. No important differences were found when unilateral hearing loss and bilateral hearing loss groups were compared. There were no significant differences in distributions of comorbidities between the patients with hearing loss and normal hearing patients.

conclusionsWe found that 30 (40.5%) of the COVID-19 positive patients had sensorineural type of hearing loss. Across all age groups, there were statistically significant differences in frequencies between the COVID-19 positive patients and the control group. There were no significant differences in distributions of comorbidities between the patients with hearing loss and normal hearing patients. Distribution of unilateral and bilateral hearing loss and audiogram types was also not significantly different between the age groups.

Indexed as

COVID-19DeafnessHearing Loss, SensorineuralAudiometry, Pure-ToneCross-Sectional StudiesFemaleHearing Loss, BilateralHumansMaleProspective StudiesAudiometryCovid-19Hearing loss

Identifiers

PMID34235578
PMCPMC8263317
OpenAlexW3178097244

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.